Boehringer Ingelheim Vetmedica has launched Prascend, the first licensed product for the treatment of Pituitary Pars Intermedia Dysfunction (PPID) in horses, commonly known as Equine Cushing's Disease.

Prascend contains pergolide mesylate, and…

Boehringer Ingelheim Vetmedica has launched Buscopan 20mg/ml injection, an antispasmodic treatment for use in cases of equine colic, and an aid to the symptomatic treatment of calf scour.

A sister product to Buscopan Compositum which contains both an…

Boehringer Ingelheim Vetmedica has launched a new Canikur Pro website - www.canikurpro.co.uk - to provide pet owners with advice on digestive upset and offer a quick reference guide to using Canikur Pro.

The site offers information about the common…

Boehringer Ingelheim Vetmedica has launched Semintra, a new liquid treatment for cats with chronic kidney disease (CKD).

The active ingredient in Semintra is telmisartan, the first angiotensin receptor blocker to be licensed in veterinary medicine.

Boehringer Ingelheim Vetmedica has launched Equisolon 33 mg/g oral powder, the first licensed oral prednisolone for the alleviation of inflammation associated with recurrent airway obstruction (RAO), otherwise known as heaves, in horses.

Clare Turnbull…

Boehringer Ingelheim has launched a 100ml bottle size for Semintra to help facilitate long-term compliance and convenience for owners of cats with chronic kidney disease (CKD).

The new bottle size will last approximately 100 days when treating an average…

Boehringer Ingelheim Animal Health has announced a change to the datasheet for Mamyzin, its antibiotic treatment for bovine mastitis.

The milk withdrawal has been reduced from 108 hours to 96 hours and the dose is now 15 mg/kg for three consecutive days…

Boehringer Ingelheim Animal Health has announced that its BRD vaccines, Bovalto Respi 3 and Bovalto Respi 4, are now licensed for use in pregnant cows.

Bovalto Respi 3 contains strains of parainfluenza virus 3, bovine respiratory syncytial virus and…

A group of seven European experts in bovine mastitis have issued a statement recommending that all cows on all farms should have an internal teat sealant administered at drying off.

The group, which was convened by Boehringer Ingelheim, made its recommendation…

Boehringer Ingelheim has launched Bovalto Respi Intranasal, an intranasal pneumonia vaccine for calves.

Bovalto Respi Intranasal protects against the two main respiratory viruses – RSV and PI3, using modified live viral strains that have been shown…

Boehringer Ingelheim Animal Health has launched Ubropen (benzylpenicillin procaine monohydrate), an intramammary suspension containing 600mg of Procaine penicillin.

The company says that the composition and dosage of the new product has been optimised…

Boehringer Ingelheim has launched Aservo EquiHaler (ciclesonide inhalation solution), the first inhaled treatment for equine asthma.

The company says the new product has been 10 years in development and uses 'Soft Mist' technology - developed originally…

Boehringer Ingelheim has launched Senvelgo (velagliflozin oral solution), a once-daily oral treatment for diabetes that cat owners can give with a small amount of food or directly into the cat’s mouth. 

Boehringer says Senvelgo controls blood sugar…

DEFRA has granted a permit allowing the use of Bultavo 3, Boehringer Ingelheim's new vaccine against bluetongue virus serotype 3 in sheep and cattle. 

The current strain of bluetongue emerged in the Netherlands in 2023 and spread rapidly, infecting…

Boehringer Ingelheim has launched a smaller, 12ml bottle of Senvelgo (velagliflozin), its treatment for feline diabetes, in Great Britain, Northern Ireland and Ireland.

This allows patients to try the drug at lower cost, before progressing to the 30ml…